Shree Ganesh [SGRL] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Shree Ganesh
BSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Shree Ganesh wins in 14 metrics, Sequent Scientific wins in 5 metrics, with 0 ties. Shree Ganesh appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shree Ganesh | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.71 | 195.40 | Shree Ganesh |
| Price-to-Book Ratio | 4.78 | 5.96 | Shree Ganesh |
| Debt-to-Equity Ratio | 26.44 | 62.47 | Shree Ganesh |
| PEG Ratio | -1.62 | 33.28 | Shree Ganesh |
| EV/EBITDA | 18.06 | 29.60 | Shree Ganesh |
| Profit Margin (TTM) | 20.16% | 1.41% | Shree Ganesh |
| Operating Margin (TTM) | 19.77% | 9.41% | Shree Ganesh |
| EBITDA Margin (TTM) | 19.77% | 9.41% | Shree Ganesh |
| Return on Equity | 15.89% | 4.35% | Shree Ganesh |
| Return on Assets (TTM) | 12.02% | 4.01% | Shree Ganesh |
| Free Cash Flow (TTM) | $74.69M | $442.70M | Sequent Scientific |
| 1-Year Return | -35.65% | 22.29% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 6.39 | 2.71 | Sequent Scientific |
| Enterprise Value | $7.04B | $46.83B | Sequent Scientific |
| EV/Revenue Ratio | 6.49 | 3.02 | Sequent Scientific |
| Gross Profit Margin (TTM) | 76.08% | 50.28% | Shree Ganesh |
| Revenue per Share (TTM) | $84 | $62 | Shree Ganesh |
| Earnings per Share (Diluted) | $17.02 | $0.86 | Shree Ganesh |
| Beta (Stock Volatility) | 0.25 | 0.91 | Shree Ganesh |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Shree Ganesh vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shree Ganesh | -0.74% | -6.27% | -7.83% | -24.44% | -33.11% | -17.95% |
| Sequent Scientific | -3.97% | -0.34% | -9.41% | 8.30% | 7.32% | -9.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shree Ganesh | -35.65% | 133.51% | 548.04% | 1,535.61% | 1,535.61% | 1,535.61% |
| Sequent Scientific | 22.29% | 57.12% | 26.68% | 13.98% | 13.98% | 13.98% |
Performance & Financial Health Analysis: Shree Ganesh vs Sequent Scientific
| Metric | SGRL | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹6.93B | ₹42.04B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,160 | 673,998 |
| 90 Day Avg. Volume | 8,256 | 526,426 |
| Last Close | ₹539.75 | ₹168.04 |
| 52 Week Range | ₹525.50 - ₹950.00 | ₹117.35 - ₹240.70 |
| % from 52W High | -43.18% | -30.19% |
| All-Time High | ₹950.05 (Jul 22, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -43.19% | -50.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.11% |
| Quarterly Earnings Growth | -0.26% | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.01% |
| Operating Margin (TTM) | 0.20% | 0.09% |
| Return on Equity (TTM) | 0.16% | 0.04% |
| Debt to Equity (MRQ) | 26.44 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹113.00 | ₹28.19 |
| Cash per Share (MRQ) | ₹22.01 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹337.14M | ₹833.62M |
| Levered Free Cash Flow (TTM) | ₹230.68M | ₹453.76M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Shree Ganesh vs Sequent Scientific
| Metric | SGRL | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.71 | 195.40 |
| Forward P/E | N/A | 33.28 |
| PEG Ratio | -1.62 | 33.28 |
| Price to Sales (TTM) | 6.39 | 2.71 |
| Price to Book (MRQ) | 4.78 | 5.96 |
| Market Capitalization | ||
| Market Capitalization | ₹6.93B | ₹42.04B |
| Enterprise Value | ₹7.04B | ₹46.83B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.49 | 3.02 |
| Enterprise to EBITDA | 18.06 | 29.60 |
| Risk & Other Metrics | ||
| Beta | 0.25 | 0.91 |
| Book Value per Share (MRQ) | ₹113.00 | ₹28.19 |
Financial Statements Comparison: Shree Ganesh vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SGRL | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹244.32M | ₹4.02B |
| Cost of Goods Sold | ₹58.44M | ₹2.00B |
| Gross Profit | ₹185.88M | ₹2.02B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹73.63M | ₹294.80M |
| EBITDA | ₹121.64M | ₹442.10M |
| Pre-Tax Income | ₹87.74M | ₹163.10M |
| Income Tax | ₹21.84M | ₹59.30M |
| Net Income (Profit) | ₹65.90M | ₹103.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SGRL | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹99.47M | ₹626.60M |
| Total Current Assets | ₹775.75M | ₹8.74B |
| Total Current Liabilities | ₹161.82M | ₹5.05B |
| Long-Term Debt | ₹296.08M | ₹3.00B |
| Total Shareholders Equity | ₹1.45B | ₹7.70B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹949.68M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SGRL | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SGRL | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,160 | 673,998 |
| Average Daily Volume (90 Day) | 8,256 | 526,426 |
| Shares Outstanding | 12.84M | 249.89M |
| Float Shares | 2.20M | 117.77M |
| % Held by Insiders | 0.76% | 0.53% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Shree Ganesh vs Sequent Scientific
| Metric | SGRL | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.33 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.15% | N/A |
| 3-Year Total Dividends | ₹1.00 | ₹0.00 |
| Ex-Dividend Date | Sep 07, 2023 | N/A |